The opioid-exposed newborn: assessment and pharmacologic management.
about
Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndromeFormulation of buprenorphine for sublingual use in neonatesOpioids in pregnancy and neonatal abstinence syndromeThe opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.Developmental consequences of fetal exposure to drugs: what we know and what we still must learnNeonatal abstinence syndrome after methadone or buprenorphine exposureHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceOral squamous cell carcinoma in a pigtailed macaque (Macaca nemestrina).Infant autonomic functioning and neonatal abstinence syndromeEpigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndromeDifferences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.Review of the assessment and management of neonatal abstinence syndromePrenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.A woman's experience of tapering from buprenorphine during pregnancy.Neonatal neurobehavior effects following buprenorphine versus methadone exposure.Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.Is periconceptional opioid use safe?Variations in opioid receptor genes in neonatal abstinence syndromePregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomesHeart rate variability evaluation in the assessment and management of in-utero drug-exposed infants.Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.Auricular acupuncture for chemically dependent pregnant women: a randomized controlled trial of the NADA protocolIn vivo regulation of the μ opioid receptor: role of the endogenous opioid agents.Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.Non-Insertive Acupuncture and Neonatal Abstinence Syndrome: A Case Series from an Inner City Safety Net Hospital.Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.Prenatal methadone exposure and neonatal neurobehavioral functioning.Evaluation and management of opioid dependence in pregnancyOpioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoNeonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics.Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.Maternal buprenorphine treatment and infant outcome.A Quality Improvement Initiative to Increase Scoring Consistency and Accuracy of the Finnegan Tool: Challenges in Obtaining Reliable Assessments of Drug Withdrawal in Neonatal Abstinence Syndrome.Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences.
P2860
Q24594941-3147414E-50B9-40D5-87BD-06790F4BA9ACQ24596701-8F5B5A8D-A536-4C36-AE67-87470E1BF24AQ28082706-715411E2-A64A-4E18-8ADF-14C1DBFD50D4Q30239085-1108ADC2-228E-45B5-9A9F-0751BEF07A8EQ30395013-7B0BDCAF-49B3-4461-A7E6-4A70308186B1Q30499416-551941D1-6C52-4278-90AA-2B5D95DF0657Q33647438-76B59B3F-0486-4BD8-B04C-3297A34C6B49Q33760424-2D8743D7-1F06-40E6-9C8F-FD9D9E068D4DQ33794646-8D806067-E351-4EA6-882D-C1CB19BF0BEFQ33872350-F70B4728-5B2E-4720-9BBD-CD3F042C605CQ34090556-45A83016-D3B0-4CBD-B271-D4C45C5070A3Q34186492-A621020F-CF26-495D-8688-5C16362583A4Q34199044-42203DEE-8F8A-4374-9F34-5D8823A322A7Q34288414-EB9906FF-7BA7-4DDC-96CD-F88F65153931Q34799869-96FB773A-03AB-4CA6-A945-54A71B968FACQ35112402-4518B796-FEBE-479A-809E-75E1AF84D981Q35220378-C7482B35-992C-47CA-B037-6D06F1C27012Q35601538-5ACC799D-88C6-49F7-8488-C92F4F562063Q35733246-F3AF1A8B-F77B-494E-901A-FCCFAF4B3C30Q35783426-7416CFDC-D478-46CC-924D-F113C45080B7Q36165958-5252B942-A215-4C55-BBDC-7EFBBDB6B2CDQ36327652-78EA0537-8182-4555-B361-F432B90AFF8BQ36362144-0D809396-79E8-4FDD-97EA-54BD1F3A95C9Q36581597-B56C2B61-89D0-42DA-BB54-EDA0F94B5042Q36670065-5B55F534-E85C-4E35-A3C4-2F97D2B8062FQ36730570-60488858-98AC-4325-BF75-87372F90C532Q36927637-9BC07749-CA1F-4A03-8E32-793B3AB22E69Q37197385-6C07A5AD-20EA-4E5E-8992-E329716AB82FQ37204964-05716AC5-2980-49EF-B538-98BF79C10F30Q37485057-434517D7-C472-4EE8-A5C5-C4015576796FQ37632852-D8575FE9-6334-4A46-B07B-10798044A8F9Q39359619-922CEECF-7018-44D3-A8A0-A4714AD9D831Q39994978-EB677AD6-D2E9-48F8-8EE2-8B097D0A22A6Q41990920-12ECD47C-63D9-4308-8282-5E01158E016FQ42172730-1BFAC8DA-A30F-42B9-B596-63DB611992C8Q47162080-D05D7E09-E11D-448E-84AC-420328E98DEDQ47712360-89EC7B07-DFCB-4C8C-98AD-3C2572972BECQ50088929-DC302FD8-E765-4158-96EF-7FF5F549C3DEQ51075571-7B355F5C-DF22-4DDC-B485-4053781BA9DDQ52611563-86301B8F-8C0A-461F-95FF-B969AB106B0A
P2860
The opioid-exposed newborn: assessment and pharmacologic management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The opioid-exposed newborn: assessment and pharmacologic management.
@en
The opioid-exposed newborn: assessment and pharmacologic management.
@nl
type
label
The opioid-exposed newborn: assessment and pharmacologic management.
@en
The opioid-exposed newborn: assessment and pharmacologic management.
@nl
prefLabel
The opioid-exposed newborn: assessment and pharmacologic management.
@en
The opioid-exposed newborn: assessment and pharmacologic management.
@nl
P2093
P2860
P1476
The opioid-exposed newborn: assessment and pharmacologic management.
@en
P2093
Cheryl Harrow
Lauren M Jansson
Martha Velez
P2860
P577
2009-01-01T00:00:00Z